b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31752957</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>18</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>18</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1465-542X</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>21</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>11</Month>\n                        <Day>21</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Breast cancer research : BCR</Title>\n                <ISOAbbreviation>Breast Cancer Res.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>123</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13058-019-1216-y</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">Development of metastases and drug resistance are still a challenge for a successful systemic treatment in breast cancer (BC) patients. One of the mechanisms that confer metastatic properties to the cell relies in the epithelial-to-mesenchymal transition (EMT). Moreover, both EMT and metastasis are partly modulated through epigenetic mechanisms, by repression or induction of specific related genes.</AbstractText>\n                <AbstractText Label="METHODS">We applied shRNAs and drug targeting approaches in BC cell lines and metastatic patient-derived xenograft (PDX) models to inhibit WDR5, the core subunit of histone H3 K4 methyltransferase complexes, and evaluate its role in metastasis regulation.</AbstractText>\n                <AbstractText Label="RESULT">We report that WDR5 is crucial in regulating tumorigenesis and metastasis spreading during BC progression. In particular, WDR5 loss reduces the metastatic properties of the cells by reverting the mesenchymal phenotype of triple negative- and luminal B-derived cells, thus inducing an epithelial trait. We also suggest that this regulation is mediated by TGF\xce\xb21, implying a prominent role of WDR5 in driving EMT through TGF\xce\xb21 activation. Moreover, such EMT reversion can be induced by drug targeting of WDR5 as well, leading to BC cell sensitization to chemotherapy and enhancement of paclitaxel-dependent effects.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">We suggest that WDR5 inhibition could be a promising pharmacologic approach to reduce cell migration, revert EMT, and block metastasis formation in BC, thus overcoming resistance to standard treatments.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Punzi</LastName>\n                    <ForeName>Simona</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Balestrieri</LastName>\n                    <ForeName>Chiara</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Humanitas University, Pieve Emanuele (MI), 20090, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Humanitas Clinical and Research Institute, Rozzano (MI), 20089, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>D\'Alesio</LastName>\n                    <ForeName>Carolina</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Present address: Department of Internal Medicine and Medical Specialties (Di.M.I), University of Genova, Genoa, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bossi</LastName>\n                    <ForeName>Daniela</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Present address: Institute of Oncology Research (IOR), Bellinzona, Switzerland.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Dellino</LastName>\n                    <ForeName>Gaetano Ivan</ForeName>\n                    <Initials>GI</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gatti</LastName>\n                    <ForeName>Elena</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pruneri</LastName>\n                    <ForeName>Giancarlo</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Biobank for Translational Medicine Unit, European Institute of Oncology, IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Present address: Istituto Nazionale dei Tumori - Fondazione IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Criscitiello</LastName>\n                    <ForeName>Carmen</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Early Drug Development for Innovative Therapy, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lovati</LastName>\n                    <ForeName>Giulia</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Meliksetyan</LastName>\n                    <ForeName>Marine</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Carugo</LastName>\n                    <ForeName>Alessandro</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institute for Applied Cancer Science, UT MD Anderson Cancer Cente, Houston, TX, 77030, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Curigliano</LastName>\n                    <ForeName>Giuseppe</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Early Drug Development for Innovative Therapy, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Natoli</LastName>\n                    <ForeName>Gioacchino</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Humanitas University, Pieve Emanuele (MI), 20090, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Humanitas Clinical and Research Institute, Rozzano (MI), 20089, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pelicci</LastName>\n                    <ForeName>Pier Giuseppe</ForeName>\n                    <Initials>PG</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lanfrancone</LastName>\n                    <ForeName>Luisa</ForeName>\n                    <Initials>L</Initials>\n                    <Identifier Source="ORCID">0000-0002-4523-3815</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy. luisa.lanfrancone@ieo.it.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>21</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Breast Cancer Res</MedlineTA>\n            <NlmUniqueID>100927353</NlmUniqueID>\n            <ISSNLinking>1465-5411</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C508960">TGFB1 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D053773">Transforming Growth Factor beta1</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C502547">WDR5 protein, human</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D058750" MajorTopicYN="N">Epithelial-Mesenchymal Transition</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015973" MajorTopicYN="N">Gene Expression Regulation, Leukemic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D064593" MajorTopicYN="N">Heterografts</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D053773" MajorTopicYN="N">Transforming Growth Factor beta1</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Breast cancer</Keyword>\n            <Keyword MajorTopicYN="Y">EMT</Keyword>\n            <Keyword MajorTopicYN="Y">Metastasis</Keyword>\n            <Keyword MajorTopicYN="Y">TGF\xce\xb21</Keyword>\n            <Keyword MajorTopicYN="Y">WDR5</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>03</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>16</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>5</Month>\n                <Day>19</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31752957</ArticleId>\n            <ArticleId IdType="doi">10.1186/s13058-019-1216-y</ArticleId>\n            <ArticleId IdType="pii">10.1186/s13058-019-1216-y</ArticleId>\n            <ArticleId IdType="pmc">PMC6873410</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Oncotarget. 2016 Dec 6;7(49):80901-80915</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27779108</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2015 Dec 1;75(23):5143-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26471359</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Future Oncol. 2009 Oct;5(8):1129-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19852726</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Rep. 2016 Jun 28;16(1):133-147</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27320920</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2017 Sep 21;36(38):5392-5406</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28534516</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2015 Sep 10;10(9):e0124964</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26355959</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Genes Dev. 2004 May 15;18(10):1131-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15155580</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Chem Biol. 2015 Aug;11(8):571-578</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26167872</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Lett. 2018 May;15(5):7864-7870</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29731905</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Trends Genet. 2017 Dec;33(12):943-959</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28919019</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Metastasis Rev. 2016 Dec;35(4):645-654</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27878502</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2017 Feb 25;389(10071):847-860</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27814965</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16493418</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2011 Apr 15;145(2):183-97</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21477851</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Chem Biol. 2018 Sep;14(9):895-900</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30013062</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Cycle. 2011 Sep 1;10(17):2865-73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21862874</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2003 Oct;112(7):1116-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14523048</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell. 2007 Mar;11(3):259-73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17349583</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sci Rep. 2015 Feb 06;5:8293</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25656485</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2007 Dec 15;67(24):11721-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18089802</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2017 Aug 15;141(4):654-663</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28369813</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2017 Nov 9;377(19):1836-1846</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29117498</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Cell Biol. 2009 Dec;11(12):1487-95</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19935649</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Stem Cells Dev. 2017 May 15;26(10):743-750</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28193136</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2015 Oct 08;10(10):e0140168</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26448330</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2008 Jul 25;134(2):215-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18662538</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Mol Life Sci. 2016 Dec;73(24):4643-4660</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27460000</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2015 Feb 1;21(3):553-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25424852</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Death Dis. 2017 Mar 16;8(3):e2686</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28300833</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Biochem. 2018 Apr;119(4):3304-3316</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29125890</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA. 2019 Jan 22;321(3):288-300</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30667505</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):8581-8586</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29987046</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Des Devel Ther. 2015 Aug 10;9:4479-99</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26309397</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2017 Jun 15;77(12):3181-3193</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28484075</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cell. 2011 Sep 2;43(5):811-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21884981</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2011 Jul 15;71(14):4846-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21750175</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Genet. 2015 May;208(5):178-91</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25794446</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Oncol. 2018 Jun;12(6):799-813</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29489064</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Oral Pathol Med. 2018 May;47(5):502-510</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29569374</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2015 May 10;6(13):10840-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25912306</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Biol Ther. 2014 Jan;15(1):128-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24253382</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2002 Dec 19;347(25):1999-2009</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12490681</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Discov. 2016 Jun;6(6):650-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27179036</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 Jun 21;7(25):37740-37754</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27192115</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>EMBO Mol Med. 2015 Apr 14;7(6):831-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25872941</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cells. 2019 Jun 18;8(6):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31216647</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2016 Jun 30;166(1):21-45</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27368099</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2010 Feb 1;70(3):968-78</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20086175</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2016 Aug 11;35(32):4244-55</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26686087</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Rep. 2013 Oct 31;5(2):302-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24120871</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Rep. 2015 Aug;34(2):877-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26062455</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2017 Jan 19;36(3):373-386</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27270440</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res Treat. 2019 Feb;173(3):573-583</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30368744</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2009 Apr 15;15(8):2657-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19336515</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Cancer. 2015 Feb 13;15:53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25884418</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'